Karyopharm Therapeutics Inc.

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Karyopharm Therapeutics Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by SELINEXOR. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: multiple myeloma, treatment adult, received least, one prior, relapsed refractory, two proteasome, immunomodulatory agents, anti-cd monoclonal. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
SELINEXOR 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Karyopharm Therapeutics Inc.

Brand nameGenericTypeRoute
XPOVIO SELINEXOR HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Karyopharm Therapeutics Inc. make?
1 FDA drug label records name Karyopharm Therapeutics Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Karyopharm Therapeutics Inc. produce?
The most frequent active ingredients in this portfolio are SELINEXOR.

Are Karyopharm Therapeutics Inc. products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.